Hanlon Investment Management’s Franklin International Low Volatility High Dividend Index ETF LVHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Buy
8,270
+1,567
+23% +$64K 0.18% 168
2026
Q1
$272K Sell
6,703
-14,876
-69% -$585K 0.15% 184
2025
Q4
$795K Buy
21,579
+1,179
+6% +$42.4K 0.44% 83
2025
Q3
$709K Buy
20,400
+2,918
+17% +$99.2K 0.43% 82
2025
Q2
$569K Buy
17,482
+2,232
+15% +$71.6K 0.41% 89
2025
Q1
$494K Buy
+15,250
New +$483K 0.37% 89

Other funds holding LVHI

Hanlon Investment Management's LVHI Position: Q2 2026 in Review

Hanlon Investment Management increased its Franklin International Low Volatility High Dividend Index ETF (LVHI) stake by 23% in Q2 2026, buying an estimated $64K and bringing the position to 8,270 shares worth $336K. The position accounts for 0.18% of the portfolio, ranked #168.

Hanlon Investment Management first reported a position in LVHI in Q1 2025 and has held it in 6 quarters since. The position peaked at $795K in Q4 2025. 311 funds tracked by Wall St. Rank hold LVHI as of Q2 2026.

  • Hanlon Investment Management held 8,270 shares of Franklin International Low Volatility High Dividend Index ETF worth $336K as of Q2 2026.
  • Hanlon Investment Management bought 1,567 Franklin International Low Volatility High Dividend Index ETF shares in Q2 2026, an estimated $64K.
  • Franklin International Low Volatility High Dividend Index ETF made up 0.18% of Hanlon Investment Management's portfolio in Q2 2026, its #168 holding.
  • Hanlon Investment Management first reported a position in Franklin International Low Volatility High Dividend Index ETF in Q1 2025 and has held it in 6 quarters since.
  • Hanlon Investment Management's Franklin International Low Volatility High Dividend Index ETF position peaked at $795K in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Franklin International Low Volatility High Dividend Index ETF as of Q2 2026.

Based on Hanlon Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.